利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

189 条记录 (耗时 0.035 秒)

    Means and method to stop bleeding from the nose
    31.
    发明授权
    Means and method to stop bleeding from the nose 有权

    公开(公告)号：US10736792B1

    公开(公告)日：2020-08-11

    申请号：US16397062

    申请日：2019-04-29

    申请人： Robert E. Fischell

    发明人： Robert E. Fischell

    IPC分类号： A61F13/20 ,  A61M31/00 ,  A61F13/00 ,  A61F13/551 ,  A61F13/38

    摘要： A blood coagulant assembly having a blood coagulant device adapted to be placed into a nostril of a patient suffering from a nose bleed. The blood coagulant device being initially placed within a blood coagulant device container which has a top section and a bottom section each secured to the other in a releasable manner. The blood coagulant device being mounted in a fixed position within the blood coagulant device container prior to removal of the blood coagulant device for insertion into a patient's nose that is bleeding. The blood coagulant device having a handle lower section and a handle upper section with a through opening passing through both the lower and upper handle sections. A blood coagulant material is secured onto an outer surface of the blood coagulant device to be placed against an inner surface of the nostril of a patient that is experiencing a bleeding nose for the purpose of stopping the nose from bleeding.

    Carotid sheath with flexible distal section
    32.
    发明授权
    Carotid sheath with flexible distal section 有权
    颈动脉鞘与柔性远端部分

    公开(公告)号：US08535294B2

    公开(公告)日：2013-09-17

    申请号：US13150308

    申请日：2011-06-01

    申请人： Robert E. Fischell ,  Timothy J. Lynch ,  Tim A. Fischell

    发明人： Robert E. Fischell ,  Timothy J. Lynch ,  Tim A. Fischell

    IPC分类号： A61M25/00

    CPC分类号： A61M25/0054 ,  A61M25/0045 ,  A61M25/005

    摘要： The present invention is a carotid sheath that has a proximal portion that is stiffer than the distal portion of the sheath as a result of the proximal portion having a higher durometer of the outer plastic coating of the sheath's proximal portion with a lower durometer for the plastic coating on the more flexible distal portion of the sheath. Another means to increase the flexibility of the sheath's distal portion compared to a stiffer proximal portion is by having a slightly smaller outside diameter for the outer plastic coating of the distal portion of the sheath. A more flexible distal portion of the sheath allows easier access for angiography, angioplasty or stenting when the sheath is used to access the tortuous path encountered when entering the carotid arteries.

    摘要翻译： 本发明是一种颈动脉鞘，其具有比鞘的远端部更硬的近端部分，因为近端部分具有较高硬度的护套近端部分的塑料涂层，其中较低的硬度计用于塑料 涂覆在护套的更柔性的远端部分上。 与较硬的近端部分相比，增加护套远端部分的灵活性的另一种手段是通过对鞘的远侧部分的外部塑料涂层具有略小的外径。 当护套用于进入进入颈动脉期间遇到的曲折路径时，鞘的更柔性的远侧部分允许更容易地进行血管造影，血管成形术或支架置入。

    Stent with optimal strength and radiopacity characteristics
    33.
    发明授权
    Stent with optimal strength and radiopacity characteristics 有权
    支架具有最佳的强度和不透射线特性

    公开(公告)号：US08454677B2

    公开(公告)日：2013-06-04

    申请号：US12007289

    申请日：2008-01-09

    申请人： Robert E. Fischell ,  David R. Fischell ,  Janet Burpee

    发明人： Robert E. Fischell ,  David R. Fischell ,  Janet Burpee

    IPC分类号： A61F2/06

    CPC分类号： A61F2/915 ,  A61F2002/91525 ,  A61F2002/91541 ,  A61F2002/91558 ,  A61F2002/91583 ,  A61F2210/0076 ,  A61F2230/0013 ,  A61F2250/0032 ,  A61F2250/0036 ,  A61F2250/0098

    摘要： A stent in the form of a thin-walled, multi-cellular tubular structure is provided. The tubular structure has a longitudinal axis and the stent includes a plurality of circumferential sets of strut members. Each set of the strut members is longitudinally displaced from each other and connected to each other by longitudinally extending links. Each set of the strut members forms a closed and cylindrical portion of the stent. Further, each set of the strut members includes a plurality of connected curve sections and diagonal sections. The sets of the strut members further include end sets of strut members located at each end of the stent and central sets of strut members located between the end sets of the strut members. The diagonal sections of the end sets of the strut members have a center portion and two ends.

    摘要翻译： 提供了薄壁多孔管状结构形式的支架。 管状结构具有纵向轴线，并且支架包括多个圆周组的支柱构件。 每组支柱构件彼此纵向移位并通过纵向延伸的连杆相互连接。 每组支柱构件形成支架的闭合和圆柱形部分。 此外，每组支柱构件包括多个连接的曲线部分和对角线部分。 支柱构件的组还包括位于支架的每个端部处的支柱构件的端组和位于支柱构件的端部组之间的支柱构件的中心组。 支柱构件的端部组的对角部分具有中心部分和两端。

    DEVICES AND METHODS FOR REDUCING SCAR TISSUE FORMATION
    38.
    发明申请
    DEVICES AND METHODS FOR REDUCING SCAR TISSUE FORMATION 审中-公开
    用于减少脊髓组织形成的装置和方法

    公开(公告)号：US20120065222A1

    公开(公告)日：2012-03-15

    申请号：US13047440

    申请日：2011-03-14

    申请人： Robert E. Fischell ,  David R. Fischell ,  Tim A. Fischell

    发明人： Robert E. Fischell ,  David R. Fischell ,  Tim A. Fischell

    IPC分类号： A61K31/436 ,  A61P17/02

    CPC分类号： A61B17/06166 ,  A61B17/064 ,  A61B2017/00831 ,  A61F2/0063 ,  A61F2013/00451 ,  A61L15/44 ,  A61L27/54 ,  A61L31/16 ,  A61L2300/416 ,  A61L2300/424 ,  A61L2300/602 ,  A61L2300/604 ,  A61L2300/622 ,  A61L2300/626

    摘要： Disclosed is a cytostatic drug attached to a sterile sheet that is designed to be placed between internal body tissues to prevent the formation of post-operative adhesions, which adhesions are really scar tissue formation. This sheet onto or into which the drug is placed may be either a permanent implant or it may be biodegradable. By impregnating an existing product such as the Johnson & Johnson SURGICEL™ absorbable hemostat gauze-like sheet with an anti-proliferative drug such as sirolimus, the biodegradable, drug impregnated mesh would act as a barrier to cell proliferation and hence be a deterrent to the formation of adhesions or scar tissue. Another embodiment of this invention is a cytostatic drug attached to a sheet that is placed at the site of an anastomosis to decrease scar tissue formation from within the vessel at the site of the anastomosis.

    摘要翻译： 公开了附着在无菌片上的细胞生长抑制药物，其被设计为放置在体内组织之间以防止术后粘连的形成，这些粘连真的是瘢痕组织形成。 药物放置在药物上或其中的片材可以是永久植入物，也可以是可生物降解的。 通过用诸如西罗莫司之类的抗增殖药物浸渍诸如Johnson＆Johnson SURGICEL TM可吸收止血纱布片的现有产品，可生物降解的药物浸渍网将作为细胞增殖的障碍，因此成为威慑 形成粘连或瘢痕组织。 本发明的另一个实施方案是连接到片材上的细胞生长抑制药物，其被放置在吻合部位以减少在吻合部位的血管内的瘢痕组织形成。

    Cardiac event detection over varying time scale
    40.
    发明授权
    Cardiac event detection over varying time scale 有权
    不同时间尺度的心脏事件检测

    公开(公告)号：US08024028B2

    公开(公告)日：2011-09-20

    申请号：US12379627

    申请日：2009-02-26

    申请人： David R. Fischell ,  Robert E. Fischell ,  Jonathan Harwood ,  Steven R. Johnson

    发明人： David R. Fischell ,  Robert E. Fischell ,  Jonathan Harwood ,  Steven R. Johnson

    IPC分类号： A61B5/04

    CPC分类号： A61N1/37235 ,  A61B5/0031 ,  A61B5/0452 ,  A61B5/0472 ,  A61B5/413 ,  A61N1/025 ,  A61N1/37247

    摘要： Disclosed is a “tracker system” that includes implanted electrical leads which are part of an implanted cardiotracker plus external equipment that includes external alarm means and a physician's programmer. The tracker system is designed to monitor the degradation of a patient's cardiovascular condition from one or more causes. These causes include the rejection of a transplanted heart and/or the progression of a stenosis in a coronary artery. As one or more stenoses in a coronary artery become progressively more narrow thereby causing reduced blood flow to the heart muscle coronary circulation, the tracker system can alert the patient by either or both internal and/or external alarm means to take the appropriate medical action. The physician's programmer can be used to display histograms of key heart signal parameters that are indicative of the patient's cardiovascular condition.

    摘要翻译： 公开了一种“跟踪器系统”，其包括植入的电引线，其是植入式心脏病治疗仪的一部分以及包括外部警报装置和医师程序员的外部设备。 跟踪器系统被设计成从一个或多个原因监测患者的心血管疾病的恶化。 这些原因包括移植心脏的排斥和/或冠状动脉狭窄进展。 由于冠状动脉中的一个或多个狭窄变得越来越窄，从而导致血液流向心脏肌肉冠状动脉循环的减少，所以跟踪器系统可以通过内部和/或外部报警装置中的一个或两个来警告患者以采取适当的医疗行动。 医师的程序员可用于显示指示患者心血管疾病的关键心脏信号参数的直方图。